| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC1051 |
| Trial ID | ChiCTR-OIN-16008064 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GPC3 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | An open-label, uncontrolled, single-arm pilot study to evaluate vascular interventional therapy mediated GPC3-targeted chimeric antigen receptor T cells in advanced hepatocellular carcinoma |
| Year | 2016 |
| Country | China |
| Company sponsor | Renji Hospital, Shanghai Jiao Tong University School of Medicine |
| Cohort 1 | |||||||
|
|||||||